EF
IDXX icon

Empowered Funds’s Idexx Laboratories IDXX Stock Holding History

Empowered Funds’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Buy
4,418
+246
+6% +$138K 0.01% 1101
2026
Q1 		$2.34M Sell
4,172
-7,985
-66% -$5.12M 0.02% 1023
2025
Q4 		$8.22M Buy
12,157
+8,225
+209% +$5.6M 0.14% 172
2025
Q3 		$2.51M Buy
3,932
+2,103
+115% +$1.28M 0.03% 795
2025
Q2 		$981K Buy
1,829
+291
+19% +$139K 0.01% 1077
2025
Q1 		$646K Buy
1,538
+95
+7% +$41.3K 0.01% 1130
2024
Q4 		$597K Buy
1,443
+133
+10% +$58.3K 0.01% 1120
2024
Q3 		$662K Buy
1,310
+36
+3% +$17.5K 0.01% 1014
2024
Q2 		$621K Buy
1,274
+235
+23% +$118K 0.01% 995
2024
Q1 		$561K Buy
1,039
+227
+28% +$124K 0.01% 1057
2023
Q4 		$451K Buy
812
+120
+17% +$56.3K 0.01% 1007
2023
Q3 		$303K Buy
692
+138
+25% +$68.8K 0.01% 1053
2023
Q2 		$278K Buy
+554
New +$265K 0.01% 988
2017
Q3 		– Sell
-4,096
Closed -$661K – 108
2017
Q2 		$661K Buy
+4,096
New +$665K 0.54% 69

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Empowered Funds's IDXX Position: Q2 2026 in Review

Empowered Funds increased its Idexx Laboratories (IDXX) stake by 5.9% in Q2 2026, buying an estimated $138K and bringing the position to 4,418 shares worth $2.33M. The position accounts for 0.01% of the portfolio, ranked #1101.

Empowered Funds first reported a position in IDXX in Q2 2017 and has held it in 14 quarters since. The position peaked at $8.22M in Q4 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Empowered Funds held 4,418 shares of Idexx Laboratories worth $2.33M as of Q2 2026.
  • Empowered Funds bought 246 Idexx Laboratories shares in Q2 2026, an estimated $138K.
  • Idexx Laboratories made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1101 holding.
  • Empowered Funds first reported a position in Idexx Laboratories in Q2 2017 and has held it in 14 quarters since.
  • Empowered Funds's Idexx Laboratories position peaked at $8.22M in Q4 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.